ARTICLE | Distillery Therapeutics
Inhibition of ATP1A2 for tauopathies including Alzheimer’s
April 1, 2022 5:04 AM UTC
DISEASE CATEGORY: Neurology
INDICATION: Alzheimer’s disease...
BCIQ Company Profiles
BCIQ Target Profiles
DISEASE CATEGORY: Neurology
INDICATION: Alzheimer’s disease...
BCIQ Company Profiles
BCIQ Target Profiles
BCIQ Company Profiles
BCIQ Target Profiles